doi:10.3389/fendo.2022.995007 Ge SX, Jung D, Yao R
The US telehealth company confirmed today that it is launching an oral version of GLP-1 agonist semaglutide the active ingredient in Wegovy at a knockdown introductory price of $49 per month with a five-month plan
Improves Brain Function L-carnitine is beneficial to both the body and the mind
Phytopathology 112, 452459
This precision neurology approach, leveraging the unique insights from circRNA, is critical to facilitating early diagnosis and treatment for Alzheimers. Trontinemab, a disease-modifying drug designed to rapidly clear amyloid plaques from the brain, is moving ahead into Phase III trials
Most clinical trials for semaglutide have focused on diabetes, weight loss, and cardiovascular health